## Abstract Three mutations in __BRCA1__ (5382insC, C61G and 4153delA) are common in Poland and account for the majority of mutations identified to date in Polish breast and breastβovarian cancer families. It is not known, however, to what extent these 3 founder mutations account for all of the BRC
β¦ LIBER β¦
High proportion ofBRCA1/2founder mutations in Hispanic breast/ovarian cancer families from Colombia
β Scribed by Diana Torres; Muhammad Usman Rashid; Fabian Gil; Angela Umana; Giancarlo Ramelli; Jose Fernando Robledo; Mauricio Tawil; Lilian Torregrosa; Ignacio Briceno; Ute Hamann
- Publisher
- Springer US
- Year
- 2006
- Tongue
- English
- Weight
- 164 KB
- Volume
- 103
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A high proportion of founder BRCA1 mutat
β
Bohdan GΓ³rski; Anna Jakubowska; Tomasz Huzarski; Tomasz Byrski; Jacek Gronwald;
π
Article
π
2004
π
John Wiley and Sons
π
French
β 71 KB
π 1 views
High proportion of novel mutations ofBRC
β
Mar Infante; Mercedes DurΓ‘n; Eva Esteban-CardeΓ±osa; Cristina Miner; Eladio Velas
π
Article
π
2006
π
Nature Publishing Group
π
English
β 227 KB
Spectrum ofBRCA1/2point mutations and ge
β
Patricio Gonzalez-Hormazabal; Sara Gutierrez-Enriquez; Daniel Gaete; Jose M. Rey
π
Article
π
2010
π
Springer US
π
English
β 218 KB
Mutation analysis ofBRCA1andBRCA2genes i
β
Andrea Pietschmann; Parvin Mehdipour; Parvin Mehdipour; Morteza Atri; Wera Hofma
π
Article
π
2005
π
Springer-Verlag
π
English
β 324 KB
Analysis ofBRCA1 andBRCA2 mutations in a
β
Moslehi, Roxana ;Karimi-Nejad, M. Hassan ;Ghafari, Vahraz ;Narod, Steven
π
Article
π
2003
π
John Wiley and Sons
π
English
β 38 KB
π 1 views
Founder BRCA1 mutations and two novel ge
β
Marco van der Looij; Barbara Wysocka; Izabela Brozek; Jacek Jassem; Janusz Limon
π
Article
π
2000
π
John Wiley and Sons
π
English
β 30 KB
π 3 views
Germline mutations in the BRCA1 and BRCA2 genes account for the majority of high-risk breast/ovarian cancer families, depending on the population studied. Previously, BRCA1 mutations were described in women from Western Poland. To further characterize the spectrum of BRCA1 mutations and the impact o